Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.52 HKD | +0.28% | +2.25% | -51.44% |
06:28am | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |
05-28 | ImmuneOnco Biopharmaceuticals Inc. Approves the Appointment of Guan Mei as Executive Director | CI |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- 1541 Stock
- Revisions ImmuneOnco Biopharmaceuticals (Shanghai) Inc.